When biotech giant Amgen recently opened its $25 million Capability Center in the Westshore business district, it meant a lot locally. As in up to 450 jobs by year’s end. As in another major biopharma presence in this market–in addition to Johnson & Johnson and Bristol-Myers Squibb. But it also meant that the market had reached the point where Amgen could choose Tampa–from virtually every MSA in the country–without state or local tax incentives being involved.